Raffael Liegl Selected Research

Retinopathy of Prematurity (Retrolental Fibroplasia)

12/2023	Treated Cases of Retinopathy of Prematurity in Germany: 10-Year Data from the Retina.net Retinopathy of Prematurity Registry.
10/2020	IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants.
1/2017	FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
11/2016	IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raffael Liegl Research Topics

Disease

9	Macular Edema 01/2022 - 01/2013
8	Choroidal Neovascularization 03/2022 - 01/2014
7	Macular Degeneration (Age-Related Maculopathy) 02/2024 - 01/2014
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018 - 04/2013
4	Retinopathy of Prematurity (Retrolental Fibroplasia) 12/2023 - 11/2016
4	Melanoma (Melanoma, Malignant) 02/2023 - 11/2021
3	Neoplasms (Cancer) 02/2023 - 01/2017
3	Pathologic Neovascularization 10/2020 - 01/2017
2	Endophthalmitis (Ophthalmia) 08/2023 - 04/2023
2	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2022
2	Hyperglycemia 10/2020 - 01/2018
2	Hypoxia (Hypoxemia) 01/2017 - 01/2014
1	Atrial Fibrillation 02/2024
1	Stroke (Strokes) 02/2024
1	Cataract (Cataracts) 08/2023
1	Hemorrhage 05/2023
1	Rupture 01/2022
1	Geographic Atrophy 01/2021
1	Atrophy 01/2021
1	Glaucoma 03/2020
1	Inflammation (Inflammations) 07/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2017
1	Retinal Neovascularization 01/2017
1	Eye Diseases (Eye Disease) 01/2017
1	Necrosis 01/2017
1	Premature Birth (Birth, Premature) 01/2016
1	Epiretinal Membrane (Epiretinal Membranes) 04/2014
1	Retinal Vein Occlusion 01/2014
1	Vascular Diseases (Vascular Disease) 01/2014
1	Scotoma (Scintillating Scotoma) 01/2014
1	Cysts 11/2013

Drug/Important Bio-Agent (IBA)

9	Retinaldehyde (Retinal)IBA 01/2022 - 04/2013
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 04/2013
4	Ranibizumab (Lucentis)FDA Link 01/2018 - 04/2013
2	Insulin (Novolin)FDA Link 10/2020 - 01/2016
2	Oxygen (Dioxygen)IBA 10/2020 - 01/2016
2	AdiponectinIBA 01/2018 - 01/2017
2	Platelet-Derived Growth FactorIBA 05/2017 - 01/2014
1	Silicone OilsIBA 08/2023
1	AnticoagulantsIBA 05/2023
1	brolucizumabIBA 01/2022
1	fluocinoloneIBA 01/2022
1	CationsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Streptozocin (Streptozotocin)FDA Link 10/2020
1	SteroidsIBA 03/2020
1	AdipoRonIBA 01/2018
1	PF-05231023IBA 01/2018
1	EnzymesIBA 07/2017
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2017
1	LipoxygenasesIBA 07/2017
1	Axitinib (AG 013736)IBA 05/2017
1	Tyrosine Kinase InhibitorsIBA 05/2017
1	LipidsIBA 04/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	G-Protein-Coupled Receptor Kinase 1 (G Protein-Coupled Receptor Kinase 1)IBA 01/2017
1	VLDL LipoproteinsIBA 01/2017
1	fibroblast growth factor 21IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	CytokinesIBA 01/2014
1	Mydriatics (Cycloplegics)IBA 01/2014

Therapy/Procedure

10	Lasers (Laser) 01/2021 - 01/2013
8	Therapeutics 02/2024 - 11/2013
3	Light Coagulation 01/2018 - 01/2014
2	Retreatment 12/2023 - 01/2013
2	Vitrectomy 08/2023 - 04/2023
2	Aftercare (After-Treatment) 02/2023 - 01/2022
2	Brachytherapy 01/2022 - 11/2021
2	Injections 01/2018 - 01/2014
1	Stents 02/2024
1	Intravitreal Injections 08/2023
1	Salvage Therapy 02/2023
1	Proton Therapy 11/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2014